Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marta Sanchez, Ortiz"'
Autor:
Karl Götze, Agathe Vrillon, Julien Dumurgier, Sandrine Indart, Marta Sanchez-Ortiz, Hela Slimi, Agathe Raynaud-Simon, Emmanuel Cognat, Matthieu Martinet, Henrik Zetterberg, Kaj Blennow, Claire Hourrègue, Elodie Bouaziz-Amar, Claire Paquet, Matthieu Lilamand
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-15 (2024)
Abstract Background Analysis of selected research cohorts has highlighted an association between plasma neurofilament light (NfL) protein and cross-sectional cognitive impairment as well as longitudinal cognitive decline. However, the findings have y
Externí odkaz:
https://doaj.org/article/72b22a4a79ff4ee783c0c7dbfa0db7ee
Autor:
Jacques Hugon, Mathieu Queneau, Marta Sanchez Ortiz, Eva Flore Msika, Karim Farid, Claire Paquet
Publikováno v:
Brain and Behavior, Vol 12, Iss 4, Pp n/a-n/a (2022)
Abstract Objective To assess FDG cerebral PET in patients suffering from cognitive impairment linked to Long COVID. The COVID pandemic has affected dozens of millions of people around the world and has resulted in the deaths of more than 3 million pe
Externí odkaz:
https://doaj.org/article/1f426ebf827049c39000a6a4a95feb16
Autor:
Jacques Hugon, Karim Farid, Mathieu Queneau, Agathe Vrillon, Eva Flore Msika, Alexandra Fayel, Marta Sanchez Ortiz, Sandrine Indart, Claire Paquet
Long COVID is often characterized by cognitive complaints and deficits occurring immediately or several weeks after the infectious disease. Neuropsychological tests can revealed attention and executive function anomalies and FDG PET can display hypom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b8cea5eab80abf44cdc73ad2c99fe4
https://doi.org/10.21203/rs.3.rs-2703691/v1
https://doi.org/10.21203/rs.3.rs-2703691/v1
Publikováno v:
La Revue du praticien. 70(2)
Autor:
Julien Dumurgier, Claire Hourregue, Claire Paquet, Clément Aveneau, Marta Sanchez-Ortiz, Emmanuel Cognat, Elodie Bouaziz-Amar
Publikováno v:
Revue Neurologique. 177:S7
Introduction L’efficacite des inhibiteurs de l’acetylcholinesterase (AChE) n’a jamais ete evaluee dans la maladie d’Alzheimer (MA) selon les nouveaux criteres de meme que l’existence de la cible therapeutique (deficit en acetycholine [ACh])